Trade Summary

3 days ago, Poulton Jeffrey V., serving as EVP, CFO at Alnylam Pharmaceuticals, Inc. (ALNY), sold 2,206 shares at $327.65 per share, for a total transaction value of $722,801.00. Following this transaction, Poulton Jeffrey V. now holds 64,330 shares of ALNY.

This sale represents a 3.00% decrease in Poulton Jeffrey V.'s stake in the company. This is considered a medium-conviction trade.

The trade was executed on Monday, March 2, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, March 4, 2026, 2 days after the trade was made.

Alnylam Pharmaceuticals, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.